Loading...
Loading...
A fresh bunch of deals were announced this morning amid the current stock market melt up.
Oliver "An Englishman in New York" Barnes is on a bit of a hot streak.
Day One Biopharmaceuticals Inc has finally confirmed little old Betaville's series of UNCOOKED Alerts about the takeover rumours surrounding the US-listed biotechnology company.
There were more signs of a rekindling of dealmaking activity in the biopharmaceutical industry this morning.
I see Canadian private equity group Brookfield last released a curious statement in response to yesterday's UNCOOKED alert about the Hikma Pharmaceuticals PLC takeover rumours.
Softbank tried to buy US-listed chip giant Marvell for over $100 billion.
Hacks at the Financial Times have dug out another cracking biotechnology takeover scoop.
Getting deals done in biopharmaceutical industry has been tough over the last few months but today FTSE 100-listed giant GlaxoSmithKline announced the $2 billion acquisition of Boston Pharmaceutical's lead asset, efimosfermin alfa.
Hat tip to hacks at Reuters who appear to have smoked out Qualcomm's interest in purchasing Alphawave IP Group by revealing takeover interest from another party.
Drax Group has launched a £200 million counter offer for the Harmony Energy Income Trust.
Perhaps the chaps at Canaccord Genuity's Quest were onto something after all with theory about how London-listed small and mid cap stocks will continue to disappear from the stock market.
The doubters continue to hurl abuse at little old Betaville but yet another one of this website's UNCOOKED Alert has now been formally confirmed.
I see G1 Therapeutics, Inc has finally agreed a deal to sell itself after little old Betaville revealed in an UNCOOKED Alert in May this year that the US-listed biotechnology company had rebuffed a takeover approach.